✦ LIBER ✦

An Open-Label Randomized Parallel-Group Comparative Study of the Efficacy of Preoperative GnRH Agonist Therapy for Laparoscopic Myomectomy

✍ Scribed by Kitade, M.; Kikuchi, I.; Kumakiri, J.; Mastuoka, S.; Jinushi, M.; Takeda, S.

Book ID: 122933510
Publisher: Elsevier Science
Year: 2011
Tongue: English
Weight: 47 KB
Volume: 18
Category: Article
ISSN: 1553-4650
DOI: 10.1016/j.jmig.2011.08.237

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

The efficacy and safety of degarelix: a

The efficacy and safety of degarelix: a 12-month, comparative, randomized, open-label, parallel-group phase III study in patients with prostate cancer

✍ Laurence Klotz; Laurent Boccon-Gibod; Neal D. Shore; Cal Andreou; Bo-Eric Persso 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 305 KB

Re: The Efficacy and Safety of Degarelix

Re: The Efficacy and Safety of Degarelix: A 12-Month, Comparative, Randomized, Open-Label, Parallel-Group Phase III Study in Patients with Prostate Cancer

✍ Dieter Jocham; Christian Doehn 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 112 KB

P43 Comparative, randomized, open label,

P43 Comparative, randomized, open label, parallel, multi centric study for efficacy and safety of lornoxicam + eperisone versus lornoxicam in the management of cervical spondylosis

✍ JC Shobha; G Narsimulu; A Hanumantha Rao; S Suresh Reddy; D Narayana Reddy; N Ba 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 77 KB

Abstract 8: A 4-Week, Randomized, Parall

Abstract 8: A 4-Week, Randomized, Parallel-Group, Open-Label Study Comparing the Efficacy of a 5% Lidocaine Patch Versus Corticosteroid Injection on Distinct Pain Qualities in Carpal Tunnel Syndrome

✍ Srinivas Nalamachu; Arnold R. Gammaitoni; Steve Crockett 📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 49 KB

Comparing the Efficacy and Tolerability

Comparing the Efficacy and Tolerability of a New Daily Oral Vitamin B12 Formulation and Intermittent Intramuscular Vitamin B12 in Normalizing Low Cobalamin Levels: A Randomized, Open-Label, Parallel-Group Study

✍ M. Cristina Castelli; Kristen Friedman; James Sherry; Karen Brazzillo; Lise Geno 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 764 KB

Efficacy and safety of the PPARγ partial

Efficacy and safety of the PPARγ partial agonist balaglitazone compared with pioglitazone and placebo: a phase III, randomized, parallel-group study in patients with type 2 diabetes on stable insulin therapy

✍ Kim Henriksen; Inger Byrjalsen; Per Qvist; Henning Beck-Nielsen; Gitte Hansen; B 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 357 KB 👁 1 views

## Abstract ## Background Treatment of patients with perioxisome proliferator‐activated receptor‐γ full agonists are associated with weight gain, heart failure, peripheral oedema, and bone loss. However, the safety of partial perioxisome proliferator‐activated receptor‐γ agonists has not been esta